have been defined for atherosclerotic lesion development but it is generally accepted that modifications of low-density lipoprotein (LDL) and profound changes in its biological effects play a fundamental role in the pathogenesis 3, 4) . On the other hand, significant reductions in death from coronary artery disease, nonfatal myocardial infarction, stroke, and transient ischemic attack are associated with an increase in the high-density lipoprotein (HDL) level 5, 6) . The body's defenses against the formation of modified low-density lipoprotein (mLDL) have been extensively studied and include anti-oxidative mechanisms and direct interaction between HDL and mLDL
Introduction
An atherosclerotic lesion involves inflammation, lipid accumulation and cell death and consists of a fibrotic cap surrounding a lipid-rich core. Intensified inflammatory activation may lead to local proteolysis, plaque rupture, and thrombus formation, which causes ischemia and infarction 1, 2) . Several risk factors sclerotic lesion is the uncontrolled uptake of mLDL by receptors present on macrophages, leading to foam cell formation 1, 10) . The uptake of foreign or autochthonous particles by macrophages involves both specific and non-specific mechanisms that can occur via several classes of receptors. In this study we decided to analyze the class B scavenger receptor CD36 that mediates the uptake of a broad variety of ligands, including oxidized LDL (oxLDL) and the Fc receptor, a known mediator of phagocytosis involved in the uptake of lipoproteins [10] [11] [12] . In the case of mLDL, the uptake and subsequent formation of foam cells can be either a rapid process involving already present receptors or a delayed process with the participation of mLDL-inducible receptors [13] [14] [15] [16] . Modifications of LDL involve both oxidative modifications, caused by oxygen reactive radical species, and enzymatic alterations processed by serumor cell-associated proteolytic enzymes 4, [17] [18] [19] [20] . These enzyme-mediated processes are likely to occur concomitantly with or independently of oxidation. These modifications are considered triggering events in the formation of atheromas.
We have previously demonstrated that HDL diminishes the capacity of macrophages to promote the phagocytosis of zymosan (an insoluble fraction of yeast cell walls) and uptake of triacylglycerol-rich emulsion particles in mouse peritoneal macrophages 21, 22) .
In an attempt to further delineate other possible effects that can explain the well-known anti-atherogenic role of HDL, we aimed to analyze the influence of HDL on the uptake of mLDL and the expression of two known receptors, CD36 and Fc RI, in this process 19, 23) . This was accomplished using LDL molecules modified by either transition-metal oxidation (Cu 2 ) or trypsin proteolysis 14, 19, 24) . Since studies based on human monocytes/macrophages often face the problem of a limited amount of cells, and further and most importantly their different stages of maturation, we used two monocytic cell lines, THP-1 and U-937. These cell lines mimic native monocytederived macrophages concerning the expression of receptors and antigens 4, 25) , and have different expressions of scavenger receptors (SR) 11, 23, 25, 26) . Further, they represent different stages of monocytic cell differentiation and in physiopathologic studies in atherosclerosis they are usually used in the differentiated stage with different stimuli. In the present study, however, we avoided strong stimuli because it is known that during in vitro culture, mainly in the presence of oxLDL, they differentiate into macrophages 4) . Our data suggest that HDL directly interferes with the rapid uptake of mLDL, thereby diminishing intracellular levels of cholesterol. This interference may involve the reduction of receptor expression on macrophages related to the uptake or phagocytosis of mLDL, and therefore represents another form of action by which HDL can be anti-atherogenic. These effects depend on the type of LDL modification and the stage of differentiation of monocytes.
Materials and Methods

Lipoprotein Isolation
Following the approval of the present experimental protocol by the Ethics Committee of the General Hospital, University of São Paulo Medical School, LDL (d 1.006 1.063 g/mL) and HDL (d 1.063 1.21 g/mL) from the plasma of healthy volunteer blood donors were isolated by sequential preparative ultracentrifugation 27) utilizing a 50 Ti rotor in an L-8 Beckman ultracentrifuge (Beckman Instruments, Palo Alto, CA, USA). LDL and HDL were dialyzed at 4 against ethylenediaminetetraacetic acid (EDTA) 1 mM in phosphate buffered saline (PBS) pH 7.4, filtered (0.22 m) and stored at 4 . The total protein concentration was determined by the Lowry method 28) .
Oxidation of LDL (oxLDL)
The oxidation of LDL was achieved according to our standard protocol 8, 13, 14) . In short, 2 mg/mL LDL were dialyzed overnight against PBS without EDTA, and then incubated with 20 M CuSO4 for 18 hours at 37 . The oxidation reaction was stopped by the addition of 1 mM EDTA, filtered (0.22 m), and stored at 4 .
Enzymatic Modification of LDL (enzLDL)
EnzLDL was made by modifying of LDL using cyanogen bromide (CNBr) Sepharose 4 resin coupled with trypsin 26) (Sigma-Aldrich Co., St Louis, MO, USA) according to the method described by the supplier. The modification was made using 23 M trypsin/ M LDL for 18 hours at 37 . Following incubation, the samples were centrifuged (1,300 g for 3 min, at room temperature). Supernatant containing enzLDL was collected and 1 mM EDTA was added to prevent further oxidation of the lipoprotein, filtered (0.22 m), and stored at 4 . The enzymatic modification was analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis 29) (SDS-PAGE) (Gibco, Carlsbad, CA, USA) to confirm the degradation (data not shown).
Conjugation of LDL with Fluorescein Isothiocyanate (FITC)
To obtain FITC-labeled native and modified LDL, LDL was conjugated with fluorescein isothiocyanate (FITC) before different modifications 30) (SigmaAldrich Co.), filtered (0.22 m), stored at 4 , and the total protein concentration was determined as described 28) . The FITC concentration in LDL preparations was determined by spectroscopy against the FITC standard at 495 nm. The F/P (fluorochrome/ protein) molar ratio was in the range of 2.4 − 3, calculated as described 31) , assuming a relative molecular mass of 389 and 550,000 for FITC and LDL, respectively. FITC-conjugated LDL was enzymatically modified or oxidized according to the conditions described above.
Determination of TBARS, Conjugated Dienes and Self-Aggregation of Lipoproteins
The extent of LDL, oxLDL, enzLDL and HDL oxidation was evaluated by measuring two parameters: the production of thiobarbituric acid reactive substances (TBARS) 13, 32) and the formation of conjugated dienes 33) . TBARS content is related to lipid peroxide levels. Briefly, 50 L LDL, oxLDL, enzLDL or HDL were incubated with 200 L TBARS reagent (tiobarbituric acid 1% w/v plus trichloroacetic acid 15% w/v) warmed at 100 for 15 min. The samples were centrifugated for 5 min and the absorbance of the supernatant was determined at 540 nm. The extent of LDL oxidation was determined as malondialdehyde (MDA) equivalents in the range of 30 − 40 nmol MDA/mg lipoprotein protein. To determine the presence of conjugated dienes, lipids were extracted from samples by chloroform-methanol (2:1), dried under nitrogen, dissolved in cyclohexane, and analyzed spectrophotometrically at 234 nm using a Multiskan MCC/340 P (Labsystems, Vantaa, Finland). Absorbance units were converted to molar units using the molar extinction coefficient 2.95 10 4 M 1 cm
1
. The results are expressed as M of conjugated dienes/mg lipoprotein protein.
To evaluate the self-aggregation of lipoproteins we analyzed the turbidity resulting from aggregation of LDL, oxLDL, enzLDL and HDL (0.5 mg protein/ mL PBS in the presence of 0.01% EDTA) by spectrophotometry at 680 nm 34) using an Ultrospec 1000 and cuvettes with 1-cm optical path (Amersham Pharmacia Biotech, Inc., Uppsala, Sweden) and the results are expressed as optical density (O.D.). Aggregated LDL (agLDL), prepared by vortexing LDL (0.5 mg protein/mL PBS in the presence of 0.01% EDTA) at room temperature for 30 seconds 14) , was used as the control for aggregation.
Fast Protein Liquid Chromatography Separation
Chromatographic profiles of LDL and mLDL were analyzed by size-exclusion column (Superdex 200 − fast protein liquid chromatography (FPLC); Amersham Biosciences, Uppsala, Sweden), according to the previously established procedure 8) . First, the concentration of the lipoprotein sample was adjusted to 1 mg/mL, filtered through a 0.45 m filter, and injected via a 0.5 mL loop into a size-exclusion column (Superdex 200), previously equilibrated with a protein molecular weight kit (13.7 − 580 kDa, Amersham Biosciences) in PBS. Fractions of 1.0 mL/min were collected and monitored by measuring UV absorbance at 280 nm using a diode array detector (Shimadzu, Kyoto, Japan).
The chromatographic profiles of LDL and mLDL conjugated or not with FITC were analyzed by anion exchange column (Resource-Q -FPLC; Amersham Biosciences), according to the previously established procedure 13) . Two solutions were used for elution: A, Tris-HCl 0.01 M, pH 7.4, and B, NaCl 1 M in buffer A. First, the concentration of the lipoprotein sample was adjusted to 1 mg/mL with Tris-HCl 0.01 M, pH 7.4, filtered through a 0.45 m filter, and injected via a 0.5 mL loop into an anion-exchange column (Resource-Q). Fractions of 1.0 mL/min were collected by a linear gradient of 5 − 42% of buffer B during the first 47 min, followed by a 42 − 100% gradient of buffer B from 47 − 52 min, a 100% gradient of Buffer B from 52 − 53 min, and 0% from 53 − 55 min. Fractions were monitored by measuring UV absorbance at 280 nm using a diode array detector (Shimadzu).
THP-1 and U-937 Cells
THP-1 (TIB-202) and U-937 (CRL-1593.2) cell lines (ATCC -The Global Bioresource Center, USA) were used in all experiments. Cells were grown in RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated fetal calf serum (FCS) (Cultilab, Campinas, SP, Brazil) and antibiotics, as previously described 35, 36) . The cells were maintained in a humid atmosphere with 5% CO2 at 37 .
Uptake of FITC-Conjugated LDL by THP-1 and U-937 Cells
Cells (5 10 5 THP-1 or U-937 cells) were plated in 0.5 mL Dulbecco's Modified Eagle's Medium (DMEM) (Gibco), in 24-well plates (Corning Costar Co., Cambridge, MA, USA) and incubated in a humid 5% CO2 atmosphere at 37 for 2 hours with LDL, oxLDL or enzLDL (10 g/mL, considered suf-ficient to promote the saturation of high affinity binding sites 15) ) conjugated with FITC in the presence or absence of excess unlabeled HDL (100 g/mL, considered sufficient to block uptake in our experiments). Nonspecific uptake was determined in the presence of unlabeled lipoprotein. Cell lines were incubated with FITC-labeled LDL, oxLDL or enzLDL in the presence of excess unlabeled LDL, oxLDL or enzLDL in a proportional dilution of (75, 100 and 125 g/mL, data not shown). After incubation, the cells were harvested by scraping since they were adherent as a result of differentiation 25) and washed with 1 mL PBS (0.1 M, pH 7.4) with 20 mM of NH4Cl. Cells were then washed with 0.5 mL PBS with 0.1% bovine serum albumin (BSA) to remove fluorescent residues and incubated with 0.5 mL of 0.02% EDTA in RPMI 1640 containing 20 mM NH4Cl for 15 min at 4 . The cell suspension was then centrifuged at 300 g for 10 min at 4 , and the pellet was fixed in 2% paraformaldehyde in PBS (0.5 mL). Uptake of LDL, oxLDL or enzLDL conjugated with FITC was analyzed by fluorescence-activated cell sorter analysis (FACS) (Beckton-Dickinson, San Jose, CA, USA) using flow cytometry. For each experiment, 10,000 events were analyzed. The fluorescence of cells without lipoproteins or FITC was used as the control. Cell counts are shown using a histogram and relative fluorescence intensity (RFI) was expressed by the analysis of labeled cells which exceeded the upper limit of autofluorescence (fluorescence within marker set M1).
Analysis of Expression of Receptors in THP-1 and U-937 Cells Incubated with LDL, oxLDL or enzLDL
For this analysis, 10 6 cells in 0.5 mL DMEM were plated in 24-well plates and incubated in a humid 5% CO2 atmosphere at 37 for 2 hours, with LDL, oxLDL or enzLDL (10 g/mL) in the presence or absence of excess HDL (100 g/mL, considered sufficient to affect receptor expression significantly in our experiments). Subsequently, the cells were harvested by scraping and the suspension was centrifuged at 300 g for 10 min at 4 . Pelleted cells were incubated with 200 L medium containing 50 L human AB serum for 15 min at room temperature, and then incubated with 10 L phycoerythrin (PE)-labeled anti-CD36 and with 10 L FITC-labeled anti-CD64 (Fc RI) monoclonal mouse antibody (BD Pharmingen, San Diego, USA) for 15 min at room temperature and in the dark. Subsequently, 2 mL PBS were added and labeled cells were centrifuged at 300 g for 10 min at 4 . The pellet was fixed in 2% paraformaldehyde in PBS (0.5 mL). The receptors were analyzed by FACS 
Statistical Analysis
Statistical analyses were performed using SigmaStat Version 3.10 (Systal Software, Inc., San Jose, CA, USA) for Windows. Oxidation data of lipoproteins are expressed as the mean standard deviation and were submitted to ANOVA using the Student Newman-Keuls contrast post-test. The percent cell expression of receptors was expressed as the median and percentiles (25 − 75) and submitted to a Kruskal-Wallis test with the Student Newman-Keuls contrast posttest. A 0.05 confidence level was considered significant.
Results
Evaluation of the Degree of LDL Modification by TBARS, Conjugated Dienes and Aggregation of Lipoproteins
We initially evaluated the degree of LDL modification prepared by different methods. Table 1 shows TBARS contents, conjugated dienes levels and selfaggregation in HDL and LDL, oxLDL, enzLDL before and after conjugation with FITC. The result indicated that, during the oxidation process, a significant increase in lipid peroxidation products (TBARS) and conjugated dienes occurred. The oxLDL showed an increase in the TBARS and conjugated dienes when compared with LDL, enzLDL or HDL. No oxidative modification was detected in enzLDL. Moderate self-aggregation was observed after LDL oxidation (oxLDL) when compared with LDL, enzLDL and HDL, although it was less than the control (LDL aggregates prepared by vortexing LDL for 30 seconds). The conjugation with FITC did not change the levels of lipid peroxidation products and aggregation of lipoproteins.
Size-Exclusion and Anion-Exchange Chromatography
The modification of LDL alters many of its physicochemical and biochemical properties 37) and this is illustrated in Fig. 1 and 2 . Protein fractions of different molecular weights in the profile of LDL after oxidation or enzymatic modification in size-exclusion chromatography (Superdex 200) were analyzed (Fig. 1) . New fractions can be observed on oxLDL and enzLDL chromatograms when compared with the LDL chromatogram; oxLDL showed two new peaks around 31 and 35 min, while enzLDL showed new and small peak protein around 33 min. Modification of the LDL particle was accompanied by an increase in negative charge components. We used an anion exchange column (Resource Q) to analyze the degree of modification of LDL particles, either by copper or trypsin treatment, and before and after their conjugation with FITC. LDL, oxLDL and enzLDL chromatograms showed an increase in negative charge components after modification, and conjugation with FITC did not change the profile of LDL and mLDL (Fig. 2) . The chromatogram of LDL and LDL FITC showed peaks between 11 and 24 min. oxLDL and oxLDL FITC showed peaks between 19 and 35 min. enzLDL and enzLDL FITC showed peaks between 18 and 33 min.
Effect of HDL on the Uptake of FITC-Conjugated LDL, oxLDL or enzLDL
Semi-quantitative measurement of the uptake of lipoproteins was conducted in THP-1 and U-937 cells after 2 hours of incubation, because the degradation of LDL is rapid after its uptake and most LDL and mLDL move to lysosomes after this period 15) . The Fig. 1 . Evaluation of the profiles of LDL, oxLDL and enzLDL by size exclusion chromatography on Superdex 200 HR using an FPLC system. 0.5 mL of the lipoprotein sample was injected at a flow rate of 1 mL/min and fraction size of 1 mL over 55 min. Fractionation was monitored by measuring ultraviolet absorbance at 280 nm using a diode array detector. represents a new protein peak.
expression was presented as relative fluorescence intensity (RFI) within the marker M2 (Fig. 3) . The measurement of cell-associated fluorescence represents uptake because NH4Cl reduces apical binding of protein through an increase in lysosomal pH, with consequent reduction of the activity of lysosomal enzymes, of binding site recycling, reducing endocytosis 38) . To ascertain the specificity of uptake, excess unlabeled oxLDL, enzLDL or LDL was used to compete with labeled fractions. Ten-fold excess of unlabeled lipoproteins (100 g/mL) was sufficient to diminish the uptake of FITC-conjugated oxLDL, enzLDL or LDL respectively in 80%, 81% and 85% in both cell lines, values considered appropriate for the good performance of a laboratory test of competition 39) confirming the specificity of binding. In THP-1 cells, 100 g/mL HDL inhibited at 19%, 37% and 21% the uptake of FITC-conjugated LDL, oxLDL and enzLDL, respectively, in relation to the uptake of FITC-conjugated LDL, oxLDL and enzLDL without HDL. Initially, different concentrations of HDL from 50 to 200 g/mL were assayed but the expected and similar effect was seen with 100 g/mL or more (data not shown); thus, 100 g/mL was chosen for subsequent experiments. The uptake of oxLDL was around two times higher than that of LDL or enzLDL. In U-937 cells, HDL diminished at 25%, 48% and 27% the uptake of FITC-conjugated LDL, oxLDL and enzLDL, respectively, in relation to the uptake of FITC-conjugated LDL, oxLDL and enzLDL without HDL. The uptake of oxLDL was more than 2 times higher than that of LDL and 1.5 times higher than that of enzLDL.
Expression of CD36 and Fc I receptors
The effect of two-hour incubation with lipoproteins on the expression of the class B scavenger receptor (CD36) and the Fc I receptor (CD64) 11, 40, 41) was subsequently analyzed. Representative data of CD36 PE versus CD64 FITC and control (mouse IgM PE versus IgG1 FITC isotypic antibodies) flow cytometry results are shown in Fig. 4 as a dot plot, where differences in percent expression were seen in either CD36 or CD64 molecules. We used four regions of cells defined as follows: R1 includes cells that express CD36 but not CD64; R2 includes cells that are both CD36 and CD64 positive; R3 includes cells that stain negatively for both CD36 and CD64, and R4 includes cells that express CD64 but not CD36. The results are expressed as the 10 g/mL of LDL, oxLDL or enzLDL was incubated in the presence or absence of HDL (100 g/mL) for 2 hours and uptake was measured by flow cytometry, analyzing 10,000 events. Fluorescence of cells in the absence of lipoproteins or FITC was used as a control. Histograms represent cell counts. Relative fluorescence intensity (RFI) is indicated in brackets and is expressed by analysis of labeled cells which exceeded the upper limit of the autofluorescence (fluorescence within the marker set M1). Results are from one representative experiment (three similar experiments were performed).
percentage of positive events in THP-1 and U-937 cells.
Differences in the expression of the class B scavenger receptor (CD36) and the Fc I receptor (CD64) after incubation with LDL, oxLDL and enzLDL in the presence or absence of HDL were analyzed ( Fig. 5  and 6 ). Data are expressed as a percentage of cells that express receptors. When compared to LDL, oxLDL induced an increase in CD36 expression in THP-1 cells but decreased in the presence of HDL. In U-937 (Fig. 5) . When analyzing enzLDL, no change in CD36 expression was seen with either LDL or enzLDL in either cell line. With enzLDL, a reduction in CD36 expression was observed in THP-1 cells when HDL was added. For U-937 cells, the reduction of expression occurred with LDL and enzLDL at this time-point. Fig. 6 illustrates how oxLDL can induce a rapid increase in the expression of Fc RI in both cell lines (but mainly in THP-1) when compared with LDL.
The addition of HDL reduced the expression induced by oxLDL in the THP-1 and U-937 cell lines. The same experiment was then repeated with enzLDL. In both cell lines, the effects of enzLDL or LDL were similar in relation to the expression of Fc RI; therefore, HDL was able to affect enzLDL-induced expression in THP-1 cells but not in U-937 cells.
Discussion
Macrophage differentiation is a necessary step for atherosclerosis 13) and it is associated with the up-regulation of pattern recognition receptors for innate immunity, including scavenger receptors (SR) 1, 2) . The formation of lipid-laden foam cells via the internalization of lipoproteins, especially LDL and its modified counterparts in the intima by scavenger receptors, represents a key event in the formation of an atherosclerotic lesion 2, 10, 42) . This process is counteracted by HDL which, until recently, was chiefly known for its role in reverse cholesterol transport 6, 9) . High LDL and low HDL levels have been established as risk factors of atherosclerotic lesion development. Moreover, there is A) Left: early uptake of LDL and mLDL modified by oxidation (mild oxidation of LDL (moxLDL) and oxLDL) or enzyme (enzLDL) in the subendothelial space. Right: suggested inhibitory mechanism of mLDL uptake by HDL. B) Uptake of mLDL by macrophage CD36 or Fc RI. Lysosomal degradation of mLDL occurs rapidly after uptake (2 hours). HDL reduces this uptake, interfering with the receptor expression.
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evidence that HDL inhibits cellular lipid accumulation by modulating the expression of CD36 43) . Analysis of TBARS and conjugated dienes clearly showed the formation of oxidation products in oxLDL only. Using size-exclusion chromatography in a recent study, our group showed a concomitant increase in TBARS and protein in various fractions of oxLDL 8) , and further conjugation of LDL with FITC did not change the concentration of MDA, conjugated dienes or retention time in FPLC. In this study, with ionexchange chromatography, the mLDL preparation used in all experiments showed peaks of oxLDL between 19 and 35 min, suggesting minimal selfaggregation in the preparation of oxLDL. This was concluded by comparing with our previous studies where peaks between 38 and 53 min were shown, probably due to extensive oxidation of LDL 14) that promoted LDL aggregation 44) since the degree of LDL oxidation is proportional to its retention time in FPLC 37) . We observed that the uptake of LDL and mLDL diminished in the presence of HDL in both cell lines, as demonstrated by the decrease in FITC-relative fluorescence intensity. This finding is in line with our previous data showing that HDL inhibits the uptake of triacylglycerol-rich emulsion particles in mouse peritoneal macrophages 21, 22) . We believe that THP-1 and U-937 cells may have catalyzed the mild oxidation of LDL (moxLDL) since we demonstrated that LDL is minimally oxidized in vitro by macrophages 14) affecting its recognition by LDL receptor 45) . HDL may have inhibited the uptake of moxLDL through SR.
Since HDL affected the uptake of LDL or mLDL, we analyzed the expression of CD36 and Fc RI, two receptors that are implicated in the uptake of lipoproteins and the development of atherosclerosis 11, 40, 41) . Various important SR are responsible for the uptake of mLDL 11) , such as SRA-I/II, CD36, Fc receptors (Fc RI, Fc RII, Fc RIII), and lectin-like oxidized LDL receptor (LOX-1); however, due to technical reasons not all receptors were analyzed and some results also suggest the participation of others, but the results obtained in the present study are consistent enough to suggest the effect of HDL on certain SR expressions.
CD36 expression in monocytes/macrophages is directly related to the increased uptake of oxLDL or enzLDL particles 13, 19) . While CD36 expression increased with oxLDL, enzLDL or LDL, the presence of HDL induced the reduction of CD36 expression in both cell lines. In THP-1 cells, CD36 expression diminished when assayed with oxLDL or enzLDL, and in U-937 cells, expression decreased with LDL, oxLDL or enzLDL. These results may explain why certain diets, which are able to reduce plasma cholesterol levels and increase HDL, can diminish CD36 expression 46) . Moreover, apolipoprotein AI, a constituent of HDL, is inversely correlated with CD36 gene expression 47) . Comparing uptake data and CD36 expression, the results are apparently controversial. While uptake of LDL was decreased in the presence of HDL, CD36 expression was not affected by HDL in THP-1 cells. It is likely that minimally oxidized LDL is internalized through other SR. Similar behavior was observed in relation to Fc I receptor in both cell lines.
Immunohistochemical analysis has shown the presence of Fc RI in human atherosclerotic coronary arteries 48) . Moreover, Fc RI mediates the clearance of immune complexes composed of LDL or oxLDL that can enhance foam cell formation 23, 48) . Here, we have shown that HDL impairs the expression of Fc RI in THP-1 cells incubated with oxLDL or enzLDL, and in U-937 cells incubated with oxLDL. Our results suggest that the expression of Fc RI is significantly diminished in the presence of HDL in an assay with mLDL. With regard to the role of antibodies in the atherosclerotic process, the present finding suggests that Fc RI inhibition is important in the prevention of atheroma formation because areas of atherosclerotic lesions have been shown to have a positive correlation with the levels of antibodies against oxLDL 49) . However, the roles of antibodies against mLDL are diverse as they can also be protective in the atherosclerotic process depending on their specificity, as shown in other studies 8, 50, 51) . Because Fc RI, in addition to its role in the formation of foam cells, is associated with inflammatory diseases 52) , our findings also suggest that HDL has anti-inflammatory properties, which include the reduction of Fc RI expression.
The mechanisms by which these receptors are reduced in the presence of HDL after co-incubation with mLDL may involve inhibition of the expression of peroxisome proliferator-activated nuclear receptor-(PPAR ), since the expression of CD36 and Fc RII involves the activation of PPAR in macrophages incubated with oxLDL 13) , and HDL affects PPAR phosphorylation, interfering with CD36 gene expression 43) . Although the incubation period was apparently short, there are data showing the inhibition of PPAR activation after four hours 53) . The formation of atheroma in atherosclerosis is a progressive phenomenon 42) that can be divided into two phases: an acute phase where rapid formation of mLDL occurs along with its consequent uptake through receptors present on the macrophages, and a second stage that subsequently initiates changes, induced by mLDL 4) , in the macrophage phenotype, such as activation or differentiation, changes in the receptor expression as CD36 and Fc RI seen here, cytokine secretion, and activation of PPAR 13, 16) . These events are intimately linked and are likely to occur during the atherosclerotic process.
We demonstrated have that LDL or mLDL promoted the differentiation of THP-1 and U-937 cells after a short period of incubation, since the expression of CD36 and Fc RI increased after incubation with LDL or mLDL as expected when they differentiated to macrophages 41, 52) . The differentiation process is also associated with increased adherence to the tissue culture dish, which was also observed 25) . We showed here that oxLDL is rapidly taken up by macrophages in less than two hours and compared this to the uptake process with enzLDL. We consider it important to analyze enzyme-modified LDL because enzLDL is generated in an inflammatory environment where proteolytic enzymes are abundant in all parts of the body 2, 20) . Even when oxygen reactive radical species are absent, LDL may be altered by inflammation and taken up by macrophages through mechanisms similar to those involved in the uptake of oxLDL 19, 20) . Our diverse results emphasize how oxLDL and enzLDL may have different roles in foam cell formation.
By measuring CD36 and Fc RI, we have demonstrated that the expression levels of these receptors were differently regulated in response to different types of LDL modifications. Interestingly, Fc RI expression was not affected by HDL in U-937 cells in an assay with enzLDL, indicating that the interaction of oxLDL and enzLDL with Fc RI may be different or may depend on the stage of differentiation of the monocyte 4, 13) . These two human cell lines are immortalized in different steps of monocyte maturation, with THP-1 cells being considered monocytic and U-937 cells being considered promonocytic 25, 35) . In summary, this study indicates that mainly mLDL induces the differentiation of THP-1 and U-937 cells, resulting in a mature macrophage-like phenotype. Moreover, we have shown that HDL plays a crucial role in the redundant mechanisms involved in protecting against atherosclerosis. The novel findings in the present study suggest that, beyond its known anti-atherogenic role in removing excess cholesterol from cells, HDL plays an active role in the inhibition of mLDL uptake by macrophages, likely through the reduction of the class B scavenger receptor CD36 and the Fc I receptor expression, disclosing another protective mechanism against the atherogenic process. According to ours results, part of the benefit would be related to the decreased expression of receptors for mLDL and the decreased uptake of these atherogenic lipoproteins. A schematic that summarizes our conclusions is shown in Fig. 7 . Further studies on cell signaling may provide knowledge on how HDL can alter important events in the development of atherosclerosis.
